Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

Pusan National University Hospital, Busan, South Korea

Chungbuk National University Hospital, Chungju, South Korea

Keimyung University Dongsan Hospital, Daegu, South Korea

Chungnam National University Hospital, Daejeon, South Korea

Chonnam National University Hospital, Gwangju, South Korea

Incheon Sejong Hospital, Incheon, South Korea

Gachon University Gil Hospital, Incheon, South Korea

Seoul National University Hospital, Seoul, South Korea

Yonsei University Health System, Severance Hospital, Seoul, South Korea

Asan Medical Center, Seoul, South Korea

Samsung Medical Center, Seoul, South Korea

The Catholic University of Korea, Seoul St.Mary, Seoul, South Korea

Koera University Guro Hospital, Seoul, South Korea

Yonsei University, Wonju Severance Christian Hospital, Wŏnju, South Korea

Pusan National University Yangsan Hospital, Yangsan, South Korea